What does the current evidence tell clinicians about the use of progestogens for prevention of preterm birth (PTB)? How should women with a previous spontaneous PTB be evaluated for risk of subsequent PTB? And what interventions have been shown to be beneficial for reducing the risk of PTB in women who do not have a history of PTB but who are found to have a short cervical length? Host Dr. Lee Shulman welcomes Dr. Baha Sibai to answer these questions and more. Dr. Sibai is Professor of the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of Texas Health Sciences Center in Houston, Texas.
Controversies in the Use of Progestogens for Prevention of Preterm Birth

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What does the current evidence tell clinicians about the use of progestogens for prevention of preterm birth (PTB)? How should women with a previous spontaneous PTB be evaluated for risk of subsequent PTB? And what interventions have been shown to be beneficial for reducing the risk of PTB in women who do not have a history of PTB but who are found to have a short cervical length? Host Dr. Lee Shulman welcomes Dr. Baha Sibai to answer these questions and more. Dr. Sibai is Professor of the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of Texas Health Sciences Center in Houston, Texas.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
FINE-HEART Pooled Analysis
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?